How Bad Is This News for Novavax?

Novavax stock fell 20% in one trading session on the news. In early pandemic days, Novavax (NVAX -1.64%) shares soared as investors bet on the company's ability to bring a coronavirus vaccine to market. But as the biotech fell behind in the race and commercialized its vaccine later than expected, the shares suffered. Earnings also weren't as bright as investors had hoped, due to this late market entrance. Moving forward, the company aimed to bring a potentially game-changing product to market: A combined co ...